Tag Archives: 2012 BIO International Convention

Analysis and Impact of PDUFA V

hamburg

As the House of Representatives voted unanimously to approve legislation to approve the Prescription Drug User Fee Act (PDUFA) V, industry leaders gathered at the 2012 BIO International Convention for a lively discussion on the changes the new legislation, focused on modernizing Food and Drug Administration regulations, will bring to the biotechnology industry. The super session panel discussion was moderated by Steve Usdin, Washington Editor of BioCentury and Co-Host of BioCentury This Week, and included Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

How to Become a Global Biotech Leader: Innovation and the Worldview Report

fareed

What are the BRICS of the future? Latin America, Korea, North Africa, Thailand, Turkey? Scientific American’s 2012 Worldview contains a special section on Emerging Markets 2.0 and an exploration of countries that are showing promise for future development and an on-the-ground look at some of the science parks, incubators, research centers, or other hot spots of innovation that are coming into their own. With the release of Worldview Report and Scorecard at the 2012 BIO Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , , , , , , ,

BIO 2012 Super Session Recap: Burrill State-of-the-Industry Report

Business Forum

“How are we doing? It’s tough.” That’s what G. Steven Burrill, CEO of Burrill & Company, said at the outset of his talk to a fully packed room at the 2012 BIO International Convention Super Session featuring an overview of the 26th annual Burrill State-of-the-Industry Report. The report’s main finding was that the biotech industry is changing at a rapid pace, and is confronting a significant and newfound adversity in austerity that is caused by Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Official Blogger Roundup

Official Blogger

Want to know what’s happening at the 2012 BIO International Convention? Find out from our BIO Official Bloggers! Early stage bio and tech tax credits – Maryland style, The Cross-Border Biotech Blog Coca Cola developing bottles using plant-based plastics #bio2012, Biotech Blog Discounted Journal of Commercial Biotechnology subscriptions through June 30 for #bio2012, Biotech Blog BIO 2012: FDA Town Hall, The Campaigns for Modern Medicine Endorser Spotlight: Virginia Biotechnology Association, The Campaigns for Modern Medicine Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Cancer Research Pioneer Dr. Margaret Foti named 2012 Biotech Humanitarian Honoree

Dr. Margaret Foti

Today, BIO named Dr. Margaret Foti, , Ph.D., M.D. (h.c.), CEO of the American Association of Cancer Research, as the 2012 Biotech Humanitarian Honoree.  Dr. Foti was honored for her tireless efforts to improve cancer research, her work as a cancer advocate and her ground-breaking work in the area of team science. Dr. Foti is also known for her work leading AACR’s scientific partnership with Stand Up To Cancer — a charitable initiative that supports Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,